BR112018074143A2 - stable topical composition and method of treating fungal infections - Google Patents

stable topical composition and method of treating fungal infections

Info

Publication number
BR112018074143A2
BR112018074143A2 BR112018074143-4A BR112018074143A BR112018074143A2 BR 112018074143 A2 BR112018074143 A2 BR 112018074143A2 BR 112018074143 A BR112018074143 A BR 112018074143A BR 112018074143 A2 BR112018074143 A2 BR 112018074143A2
Authority
BR
Brazil
Prior art keywords
stable topical
topical composition
fungal infections
treating fungal
stable
Prior art date
Application number
BR112018074143-4A
Other languages
Portuguese (pt)
Inventor
Rameshchandra Dhuppad Ulhas
Babulal Bhamre Nitin
Sarjerao Gaikwad Prashant
Ramadasswami Alai Vivek
Original Assignee
Glenmark Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Pharmaceuticals Ltd filed Critical Glenmark Pharmaceuticals Ltd
Publication of BR112018074143A2 publication Critical patent/BR112018074143A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

a presente invenção refere-se a composições tópicas estáveis que compreendem luliconazol. além disso, a presente invenção também se refere a composições tópicas estáveis que compreendem uma combinação de luliconazol com um corticosteroide, tal como betametasona ou clobetasol. as composições são livres de álcool alifático e cetona.The present invention relates to stable topical compositions comprising luliconazole. In addition, the present invention also relates to stable topical compositions comprising a combination of luliconazole and a corticosteroid such as betamethasone or clobetasol. The compositions are free of aliphatic alcohol and ketone.

BR112018074143-4A 2016-05-25 2017-05-25 stable topical composition and method of treating fungal infections BR112018074143A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201621017933 2016-05-25
IN201621017933 2016-05-25
PCT/IB2017/053078 WO2017203456A1 (en) 2016-05-25 2017-05-25 Luliconazole stable topicalcompositions

Publications (1)

Publication Number Publication Date
BR112018074143A2 true BR112018074143A2 (en) 2019-04-16

Family

ID=60411128

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018074143-4A BR112018074143A2 (en) 2016-05-25 2017-05-25 stable topical composition and method of treating fungal infections

Country Status (4)

Country Link
BR (1) BR112018074143A2 (en)
MX (1) MX2018014485A (en)
RU (1) RU2018141796A (en)
WO (1) WO2017203456A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017216722A2 (en) * 2016-06-13 2017-12-21 Vyome Biosciences Pvt. Ltd. Synergistic antifungal compositions and methods thereof
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5313905B2 (en) * 2007-08-27 2013-10-09 日本農薬株式会社 Fungal dermatitis agent
JP5686874B2 (en) * 2012-09-14 2015-03-18 株式会社ポーラファルマ Pharmaceutical composition
WO2015156219A1 (en) * 2014-04-07 2015-10-15 日本農薬株式会社 Pharmaceutical composition including anti-fungal agent and steroid

Also Published As

Publication number Publication date
RU2018141796A (en) 2020-06-25
MX2018014485A (en) 2019-08-12
WO2017203456A1 (en) 2017-11-30
RU2018141796A3 (en) 2020-08-27

Similar Documents

Publication Publication Date Title
BR112018010720A8 (en) apelin receptor agonists and methods of use
MX2018012016A (en) Bicyclic compounds.
CO2017011851A2 (en) Novel compounds
BR112018068341A2 (en) 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as apj agonists
MX2018012486A (en) Compositions for topical application of compounds.
CL2020000632A1 (en) Composition and method for the treatment of autism.
UY36705A (en) 4-HYDROXI-3- (HETEROARIL) PIRIDIN-2-ONA COMPOUNDS AS APJ AGONISTS
BR112017017727A8 (en) BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS
MX2017004896A (en) Use of hexadeca-8,15-dienal as aroma chemical.
BR112018067538A2 (en) small molecule ire1-alpha inhibitors
UY36949A (en) 2,4-DIHIDROXI-NICOTINAMIDS AS APJ AGONISTS
BR112016023851A2 (en) ? two-part coating composition and method for coating a surface?
BR112017018187A2 (en) compositions comprising combinations of organic acids
CR20170425A (en) NEW SPECIFIC PROTEINS FOR PIOVERDINA AND PIOQUELINA
MY193175A (en) Apremilast pharmaceutical compositions
MX2019013419A (en) Bicyclic pesticidal compounds.
BR112018006314A2 (en) formula compound, composition, use of formula compound, method of combating phytopathogenic fungi and coated seed
BR112017019352A2 (en) corticosteroid-compressed topical compositions related applications
BR112017018172A2 (en) compositions comprising combinations of organic acids
BR112018010945A2 (en) formulations with reduced polysorbate degradation
MX369223B (en) Sunscreen compositions.
ECSP17024579A (en) TREATMENT METHOD FOR ANTI-SPOTTING OF TUBERCULES WITH REDUCED QUANTITY OF CIPC
BR112018074143A2 (en) stable topical composition and method of treating fungal infections
BR112018008588A2 (en) composition, and process for preparing a composition.
EA201890075A1 (en) INJECTABLE PHARMACEUTICAL COMPOSITIONS LEFAMULIN

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements